BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization: BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period: 2017-01-01 to 2017-12-31
Filed: 2018-11-07
IRS object ID: 201823119349301002
Schema version: 2017v2.3
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule L
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2018-11-07T07:20:45-06:00	ReturnTs
Tax Period End	2017-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	410746749	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	CLIFTONLARSONALLEN LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	901 N GLEBE ROAD SUITE 200	AddressLine1Txt
City	ARLINGTON	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22203	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2017-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	521224577	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BIOTECHNOLOGY INNOVATION ORGANIZATION	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BIOT	BusinessNameControlTxt
Phone	2029629200	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 MARYLAND AVENUE SW NO 900	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20024	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	YVETTE WHITE-WIGGINS	PersonNm
Person Title	CFO AND SVP, FINANCE & ADMIN	PersonTitleTxt
Phone	2029629200	PhoneNum
Signature	2018-10-30	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	IVY BECKHAM	PreparerPersonNm
PTIN	P01316131	PTIN
Phone	5712279500	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	67.137.57.251	IPv4AddressTxt

Field	Value	IRS element (for citing)
IP	2018-10-30	IPDt
IP Tm	00:18:05	IPTm
IP Timezone	ED	IPTimezoneCd
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	117C9FDD72C608EEAC637569487DFDD6D3A36660	AtSubmissionCreationDeviceId
At Submission Filing Device Id	117C9FDD72C608EEAC637569487DFDD6D3A36660	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2017	TaxYr
Build TS	2019-02-21 02:37:17Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	JAMES C GREENWOOD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 MARYLAND AVENUE SW NO 900	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20024	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$83,749,665	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c	Yes (X)	Organization501cInd
Website Address	WWW.BIO.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1993	FormationYr
Legal Domicile State	DC	LegalDomicileStateCd
Activity Or Mission	SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND.	ActivityOrMissionDesc
Voting Members Governing Body	113	VotingMembersGoverningBodyCnt
Voting Members Independent	113	VotingMembersIndependentCnt
Total Employee	208	TotalEmployeeCnt
Total Volunteers	167	TotalVolunteersCnt
Total Gross UBI	$713,427	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	-$31,277	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$0	PYContributionsGrantsAmt
CY Contributions Grants	$0	CYContributionsGrantsAmt
PY Program Service Revenue	$64,830,661	PYProgramServiceRevenueAmt
CY Program Service Revenue	$66,032,153	CYProgramServiceRevenueAmt
PY Investment Income	$1,712,696	PYInvestmentIncomeAmt
CY Investment Income	$2,716,705	CYInvestmentIncomeAmt
PY Other Revenue	$10,372,053	PYOtherRevenueAmt
CY Other Revenue	$9,803,104	CYOtherRevenueAmt
PY Total Revenue	$76,915,410	PYTotalRevenueAmt
CY Total Revenue	$78,551,962	CYTotalRevenueAmt
PY Grants And Similar Paid	$596,583	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$785,500	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$31,655,808	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$34,575,243	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$47,122,286	PYOtherExpensesAmt
CY Other Expenses	$42,956,281	CYOtherExpensesAmt
PY Total Expenses	$79,374,677	PYTotalExpensesAmt
CY Total Expenses	$78,317,024	CYTotalExpensesAmt
PY Revenues Less Expenses	-$2,459,267	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$234,938	CYRevenuesLessExpensesAmt
Total Assets BOY	$73,322,307	TotalAssetsBOYAmt
Total Assets EOY	$81,025,145	TotalAssetsEOYAmt
Total Liabilities BOY	$33,540,196	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$34,368,598	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$39,782,111	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$46,656,547	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Desc	ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2017 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2017 ADVOCACY ACCOMPLISHMENTS: - ADVOCATED FOR THE PASSAGE OF THE 21ST CENTURY CURES ACT - SUCCESSFULLY FINISHED NEGOTIATIONS ON REAUTHORIZING THE PRESCRIPTION DRUG USER FEE ACT TO IMPROVE THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2017 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.- SUPPORTED THE SEC SMALL BUSINESS ADVOCATE ACT TO ENHANCE THE ROLE OF SMALL BUSINESSES IN THE SEC'S DECISION-MAKING PROCESS, WHICH WAS SIGNED INTO LAW BY PRESIDENT OBAMA IN DECEMBER 2016.THE FOOD & AGRICULTURE SECTION 2017 ADVOCACY ACCOMPLISHMENTS: - SUCCESSFULLY ADVOCATED FOR PASSAGE OF THE NATIONAL BIOENGINEERED FOOD DISCLOSURE LAW - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT MANDATING GMO FOOD LABELING.- ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2017 ADVOCACY ACCOMPLISHMENTS: - PRODUCED A RENEWABLE CHEMICALS REPORT TO CAPTURE THE BROAD SCOPE OF TECHNOLOGIES, PARTNERSHIPS, AND RAPID GROWTH OF THE RENEWABLE CHEMICALS SECTOR.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE PASSAGE AND IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- SUCCESSFULLY SECURED POSITIVE CHANGES TO EPA'S FINAL RENEWABLE FUEL STANDARDS (RFS) RULE FOR 2017. - URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2017.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Desc	SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2017, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF OVER 35,700 PARTNERING MEETINGS AMONG MORE THAN 3,400 COMPANIES, ALONG WITH 192 COMPANY PRESENTATIONS, OVER 800 SPEAKERS, 1,800 EXHIBITIONS WITH 50 INTERNATIONAL, REGIONAL AND STATE PAVILIONS AND SEVEN PRODUCT FOCUS ZONES.BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.	Desc

Field	Value	IRS element (for citing)
Described In Section501c3	0	DescribedInSection501c3Ind
Schedule B Required	0	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Subject To Proxy Tax	Yes (1)	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Temp Or Permanent Endowments	0	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	0	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	0	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	0	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	0	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	Yes (1)	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	0	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	0	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	158	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Employee	208	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (1)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (1)	Form990TFiledInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	IN	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	113	GoverningBodyVotingMembersCnt
Independent Voting Member	113	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (1)	MembersOrStockholdersInd
Election Of Board Members	Yes (1)	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	0	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	YVETTE WHITE-WIGGINS	PersonNm
Phone	2029629200	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 MARYLAND AVENUE SW SUITE 990	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20024	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (158 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
JOHN MARAGANORE
CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
RON COHEN MD
CHAIR, IMMEDIATE PAST CHAIR	2.00	Yes (X)	Yes (X)	$0	$0	$0
BRADFORD A ZAKES
TREASURER	2.00	Yes (X)	Yes (X)	$0	$0	$0
JULIE GERBERDING
SECRETARY	2.00	Yes (X)	Yes (X)	$0	$0	$0
DAVID P MEEKER
SECRETARY (PARTIAL YEAR)	2.00	Yes (X)	Yes (X)	$0	$0	$0
ABBIE CELNIKER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ADAM MONROE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ADELENE PERKINS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ALAN SHAW
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ALBERT BOURLA
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
AMIR NASHAT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ANNA RATH
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ANNE PHILLIPS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BASSIL I DAHIYAT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BENJAMIN R KNUDSEN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BILL ANDERSON
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BILL SIBOLD
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BRIAN BARKER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
BRIAN THOME
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
C DAVID NICHOLSON
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CARLOS PAYA
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CARSTEN BRUNN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CHRISTI L SHAW
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CHRISTOPHER HEALEY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CHRISTOPHER STANDLEE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
CLIVE MEANWELL
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DAN MEAGHER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DAPHNE PREUSS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DAVID MAIN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DAVID STACK
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DEBORAH DUNSIRE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DOUG BERVEN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
DOUGLAS DOERFLER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
EDDIE SULLIVAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ELIZABETH LEWIS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
FRANK TERHORST
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
GARY ZIEZIULA
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
GIL VAN BOKKELEN PHD
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
GOERGE A SCANGOS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
H THOMAS WATKINS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
HELEN TORLEY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
HERVE HOPPENOT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
HOWARD ROBIN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
HUGH C WELSH JD
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JAMES SAPIRSTEIN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JAMES SULLIVAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEAN-CHRISTOPHE TELLIER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEAN-JACQUES BIENAIME
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEFF KINDLER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEFFREY CLELAND
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEFFREY MARRAZZO
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JENNIFER HOLMGREN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JENNIFER TAUBERT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JEREMY LEVIN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JERRY FLINT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JIM MEYERS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOEL MARCUS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOHN CROWLEY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOHN LEPORE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOHN MELO
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOHN SWART
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOSEPH LAROSA
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
JOSHUA OFMAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
KATRINE BOSLEY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
KENNETH MOCH
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
KIRAN MAZUMDAR-SHAW
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
LAURA BEREZIN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
LONNIE MOULDER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK DROZDOWSKI
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK ENYEDY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK JONES
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK PRUZANSKI
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK SKALETSKY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARK TRUDEAU
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MARTIN BABLER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MAXINE GOWEN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MICHAEL MORRISSEY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MICHAEL NARACHI
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MICHAEL RAAB
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
MICHAEL RYAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
NANCY SIMONIAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
NICK LESCHLY
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PAUL BACKMAN
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PAUL HASTINGS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PAUL MCKENZIE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PERRY STERNBERG
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PETER GREENLEAF
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
PHILIP MILLER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
RACHEL KING
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
RICHARD POPS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
RICK WINNINGHAM
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ROBERT WILLS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ROGER WYSE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
RONALD STOTISH
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
RUSSELL HERNDON
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SABINE LUIK
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SANDY MACRAE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SCOTT GARLAND
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SCOTT HOLMSTROM
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SCOTT KOENIG
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SCOTT SMITH
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SHAJ PROCIDA
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
SIMON WADDINGTON
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
STEVEN MENTO
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
STEVEN PAUL
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
STUART A ARBUCKLE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
TAMMY LEE STANOCH
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
TED W LOVE
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
THOMAS WIGGANS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
TIMOTHY P WALBERT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
TJERK DE RUITER
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
VINCENT SEWALT
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
WILLIAM FITZSIMMONS
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
WILLIAM NEWELL
BOARD MEMBER	2.00	Yes (X)		$0	$0	$0
ALEX AZAR
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
ALLEN WAXMAN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
CHRISTIAN NOLET
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
CHRISTOPH WESTPHAL
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
CHRISTOPHER BOERNER
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
CRAIG LANDAU
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
ELI BEN-SHOSHAN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
EMIL KAKKIS
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
GARY PHILLIPS
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
GLENN GORMLEY
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
HAROLD E VAN WART PHD
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
HENRI A TERMEER
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JAMES HEALY
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JAMES LEVINE
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JAY SIEGEL
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JEAN-FRANCOIS FORMELA
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JOHN MENDLEIN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JOHN ORWIN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JONATHAN LEFF
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JONATHAN WOLFSON
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JOSEPH SHAULSON
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
KATHLEEN TREGONING
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MARK ALLES
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MARK TIMNEY
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MARKUS POMPEJUS
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MICHAEL KNUTZEN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MICHELLE DIPP
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
MONCEF SLAOUI
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
NEIL GOLDSMITH
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
NEIL K WARMA
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
PAUL EISENBERG
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
PERRY KARSEN
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
ROBERT REPELLA
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
THOMAS MATHERS
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
WILLIAM HINSHAW
BOARD MEMBER (PARTIAL YEAR)	2.00	Yes (X)		$0	$0	$0
JAMES C GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER	40.00		Yes (X)	$4,382,224	$0	$888,749
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER	40.00		Yes (X)	$404,050	$0	$70,851
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY DIV	40.00			$701,370	$0	$71,486	Yes (X)
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIV	40.00			$701,370	$0	$66,932	Yes (X)
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT	40.00			$518,015	$0	$55,320		Yes (X)
DANIEL DURHAM
EVP, HEALTH POLICY	40.00			$579,487	$0	$69,241		Yes (X)
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY	40.00			$429,503	$0	$50,968		Yes (X)
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS	40.00			$480,493	$0	$72,041		Yes (X)
KATHLEEN HOLCOMBE
SVP, SCIENCE POLICY (PARTIAL YEAR)	40.00			$434,445	$0	$9,150		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$8,630,957	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$1,354,738	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	95	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
FREEMAN EXPOSITIONS
PO BOX 660613	DALLAS	TX	75266	CONVENTION & CONFERENCES GENERAL CONTRAC	$2,289,565
CENTERPLATE
111 WEST HARBOR DRIVE	SAN DIEGO	CA	92101	CATERING	$1,096,032
WHITE64
8603 WESTWOOD CENTER DRIVE 4TH FLO	TYSONS	VA	22182	COMMUNICATION SERVICES	$934,546
PROJECTION INC
PO BOX 890472	CHARLOTTE	NC	28289	AV	$873,243
SAN DIEGO PADRES
100 PARK BOULEVARD	SAN DIEGO	CA	92101	CONVENTION RECEPTION	$643,492

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	91	CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MEETING REVENUE	541800	$36,155,018	$35,861,488	$293,530
MEMBERSHIP DUES	900099	$28,470,916	$28,470,916
EPF MEMBER SUPPORT	900099	$900,000	$900,000
INTERNATIONAL EFFORTS	900099	$336,500	$336,500
LEGAL & POLICY SUPPORT	900099	$169,719	$169,719

Field	Value	IRS element (for citing)
Total Program Service Revenue	$66,032,153	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,771,610	TotalRevenueColumnAmt
Exclusion	$1,771,610	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$9,616,356	TotalRevenueColumnAmt
Unrelated Business Revenue	$384,654	UnrelatedBusinessRevenueAmt
Exclusion	$9,231,702	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$40,244	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$40,244	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$6,102,554	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$5,157,459	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$945,095	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$945,095	TotalRevenueColumnAmt
Exclusion	$945,095	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
CBI	900099	$119,706	$119,706
BIONEWS ADS INCOME	541800	$32,072		$32,072
JOB BOARD	900004	$3,171		$3,171

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$31,799	TotalRevenueColumnAmt
Exclusion	$31,799	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$186,748	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$78,551,962	TotalRevenueColumnAmt
Related Or Exempt Func Income	$65,858,329	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$713,427	UnrelatedBusinessRevenueAmt
Exclusion	$11,980,206	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$785,500	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$7,287,032	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$21,478,885	TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,218,651	TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$3,088,672	TotalAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,502,003	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$355,633	TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$70,894	TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$3,176,909	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$55,567	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$8,535,085	TotalAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$365,565	TotalAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$692,979	TotalAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,436,486	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$4,111,480	TotalAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$1,621,449	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$16,110,899	TotalAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$2,371	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$3,703,359	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$630,358	TotalAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$120,496	TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt
DUES & SUBSCRIPTIONS	$1,334,958
OUTREACH	$347,499
TAXES PAID	$83,896
BAD DEBT EXPENSE	$10,000

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$190,398	TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$78,317,024	TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$5,985,669	BOYAmt
EOY	$6,917,248	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$2,007,963	BOYAmt
EOY	$3,265,043	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$3,650,322	BOYAmt
EOY	$3,137,266	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$2,073,003	BOYAmt
EOY	$2,686,112	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$10,206,512	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$9,264,135	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$1,572,895	BOYAmt
EOY	$942,377	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$58,032,455	BOYAmt
EOY	$64,077,099	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$73,322,307	BOYAmt
EOY	$81,025,145	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$17,667,769	BOYAmt
EOY	$17,217,909	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$11,510,981	BOYAmt
EOY	$13,458,572	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$4,361,446	BOYAmt
EOY	$3,692,117	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$33,540,196	BOYAmt
EOY	$34,368,598	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$39,782,111	BOYAmt
EOY	$46,656,547	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$39,782,111	BOYAmt
EOY	$46,656,547	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$73,322,307	BOYAmt
EOY	$81,025,145	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$234,938	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$6,639,498	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Substantially All Dues Nonded	0	SubstantiallyAllDuesNondedInd
Only In House Lobbying	0	OnlyInHouseLobbyingInd
Agree Carryover Prior Year	Yes (1)	AgreeCarryoverPriorYearInd
Dues Assessments	$28,470,916	DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY	$10,223,685	NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov	-$566,403	NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot	$9,657,282	NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc	$9,395,402	AggregateReportedDuesNtcAmt
Carried Over	$261,880	CarriedOverAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$6,183,755	OtherCostOrOtherBasisAmt
Depreciation	$5,495,611	DepreciationAmt
Book Value	$688,144	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$788,262	OtherCostOrOtherBasisAmt
Depreciation	$785,668	DepreciationAmt
Book Value	$2,594	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$3,234,495	OtherCostOrOtherBasisAmt
Depreciation	$2,982,856	DepreciationAmt
Book Value	$251,639	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$942,377	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDesc	AmtAmt
CAPITAL LEASE OBLIGATION	$2,518
DEFERRED RENT	$3,689,599

Field	Value	IRS element (for citing)
Total Liability	$3,692,117	TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt	$88,228,246	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$6,639,498	NetUnrealizedGainsInvstAmt
Other Revenue	$3,052,109	OtherRevenueAmt
Revenue Not Reported	$9,691,607	RevenueNotReportedAmt
Revenue Subtotal	$78,536,639	RevenueSubtotalAmt
Investment Expenses Not Incld	$55,567	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$40,244	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$15,323	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$78,551,962	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$81,353,810	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	$3,092,353	OtherExpensesIncludedAmt
Expenses Not Reported	$3,092,353	ExpensesNotReportedAmt
Expenses Subtotal	$78,261,457	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$55,567	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$55,567	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$78,317,024	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:	FOOD & AG SGR FUND 2,540,774. FOOD & AG LEGAL FUND 11,992. BIOSIMILARS REVENUE 439,343. FGR SPECIAL INITIATIVES REVENUE 60,000.
PART XI, LINE 4B - OTHER ADJUSTMENTS:	RENTAL EXPENSES -40,244.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	FOOD & AG LEGAL FUND EXPENSES 11,992. BIOSIMILAR EXPENSES 439,343. FGR SPECIAL INITIATIVE EXPENSES 60,000. FOOD & AG SGR FUND 2,540,774. RENTAL EXPENSES 40,244.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,	2	PROGRAM SERVICES	CONFERENCES, ADVOCACY	$388,931
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	2	PROGRAM SERVICES	CONFERENCES, ADVOCACY AND EDUCATION	$252,030
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,	0	PROGRAM SERVICES	ADVOCACY	$13,391
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES	0	PROGRAM SERVICES	CONFERENCES, ADVOCACY	$828,561
SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR,	1	PROGRAM SERVICES	ADVOCACY	$55,507
SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL,	0	PROGRAM SERVICES	ADVOCACY	$64,533

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	5	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	5	TotalEmployeeCnt
Subtotal Spent	$1,602,953	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$1,602,953	TotalSpentAmt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (37 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740	WASHINGTON	DC	20006	541379174	501(C)(3)	$15,000	SPONSORSHIP
AMERICAN CANCER SOCIETY ACTION NETWORK INC
555 11TH STREET SUITE 300	WASHINGTON	DC	20004	522340031	501(C)(4)	$40,000	SPONSORSHIP
AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH
1789 MASSACHUSETTS AVENUE NW	WASHINGTON	DC	20036	530218495	501(C)(3)	$15,000	SPONSORSHIP
BIO NEBRASKA LIFE SCIENSES ASSOCIATION
PO BOX 24802	OMAHA	NE	68124	202214508	501(C)(6)	$6,000	SPONSORSHIP
BIO OHIO
1275 KINNGAR ROAD	COLUMBUS	OH	43212	341577705	501(C)(6)	$6,000	SPONSORSHIP
BIOCENTURY PUBLICATIONS
1235 RADIO ROAD SUITE 100	REDWOOD CITY	CA	94065	943164558	N/A	$15,000	SPONSORSHIP
BIOTECH COUNCIL OF NEW JERSEY
1255 WHITEHORSE-MERCERVILLE ROAD	TRENTON	NJ	08619	223284393	501(C)(6)	$10,000	SPONSORSHIP	BLDG B SUITE 514
CANCER SUPPORT COMMUNITY
734 15TH STREET NW SUITE 300	WASHINGTON	DC	20005	954163931	501(C)(3)	$10,000	SPONSORSHIP
CHAMBER OF COMMERCE OF THE USA
1615 H STREET NW	WASHINGTON	DC	20062	530045720	501(C)(6)	$60,000	GENERAL SUPPORT
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET NO 306	DENVER	CO	80203	841363258	501(C)(6)	$7,500	SPONSORSHIP
EVERYLIFE FOUNDATION FOR RARE DISEASES
77 DIGITAL DRIVE SUITE 210	NOVATO	CA	94949	264614274	501(C)(3)	$10,000	SPONSORSHIP
FAEGRE BAKER DANIELS
75 REMITTANCE DRIVE DEPT 6952	CHICAGO	IL	606756952	410244008	N/A	$10,000	CONTRIBUTION
FISHER HOUSE FOUNDATION INC
12300 TWINBROOK PARKWAY SUITE 410	ROCKVILLE	MD	20852	113158401	501(C)(3)	$15,000	CONTRIBUTION
FUELSAMERICA
607 FORT WILLIAMS PARKWAY	ALEXANDRIA	VA	22304	460991009	501(C)(4)	$250,000	GENERAL SUPPORT
GALIEN FOUNDATION
99 JOHN STREET SUITE 2502	NEW YORK	NY	10038	264549935	501(C)(3)	$15,000	SPONSORSHIP
GEORGIA BIO
999 PEACHTREE STREET NE	ATLANTA	GA	30307	581849665	501(C)(6)	$7,500	SPONSORSHIP
GLOBAL GENES
28 ARGONAUT SUITE 150	ALISO VIEJO	CA	92656	263331487	501(C)(3)	$10,000	SPONSORSHIP
HUDSON INSTITUTE
1201 PENNSYLVANIA AVENUE NW SUITE	WASHINGTON	DC	20004	131945157	501(C)(3)	$50,000	GENERAL SUPPORT	400
KEYSTONE CENTER
1628 SAINT JOHN ROAD	KEYSTONE	CO	80435	840688506	501(C)(3)	$10,000	SPONSORSHIP
LEUKEMIA & LYMPHOMA SOCIETY INC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	135644916	501(C)(3)	$10,000	SPONSORSHIP
LIFE SCIENCE PENNSYLVANIA
650 EAST SWEDESFORD ROAD NO 190	WAYNE	PA	19087	251621500	501(C)(6)	$22,000	SPONSORSHIP
LYCHEE GROUP LLC
5 CREST FRUIT COURT	MANALAPAN	NJ	07726	262070716	N/A	$10,000	SPONSORSHIP
MD TECHNOLOGY COUNCIL
9841 WASHINGTONIAN BOULEVARD	GAITHERSBURG	MD	20878	204950778	501(C)(6)	$7,500	SPONSORSHIP
MEDMATES INC
24 CORLISS STREET 42240	PROVIDENCE	RI	02904	462858053	501(C)(6)	$6,000	SPONSORSHIP
NATIONAL COALITION FOR CANCER SURVIVORSHIP
8455 COLESVILLE ROAD SUITE 930	SILVER SPRING	MD	20910	850357897	501(C)(3)	$10,000	SPONSORSHIP
NATIONAL HEALTH COUNCIL
1730 M STREET NW SUITE 500	WASHINGTON	DC	200364561	131624107	501(C)(3)	$25,000	SPONSORSHIP
NEHI
ONE BROADWAY 15TH FLOOR	BOSTON	MA	02142	010624865	501(C)(3)	$15,000	SPONSORSHIP
NO LABELS
1130 CONNECTICUT AVE NW SUITE 325	WASHINGTON	DC	20036	271432208	501(C)(4)	$25,000	CONTRIBUTION
NUS AMERICA FOUNDATION
440 NORTH WOLFE ROAD	SUNNYVALE	CA	94085	202368621	501(C)(3)	$15,000	GENERAL SUPPORT
OREGON BIOSCIENCE
2828 SW CARBETT AVENUE SUITE 115	PORTLAND	OR	97201	931009329	501(C)(6)	$10,000	SPONSORSHIP
PARENT PROJECT FOR MUSCULAR DYSTROPHY RESEARCH INC
401 HACKENSACK AVENUE 9TH FLOOR	HACKENSACK	NJ	07601	311405490	501(C)(3)	$12,000	SPONSORSHIP
PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA
950 F STREET NW SUITE 300	WASHINGTON	DC	20004	530241211	501(C)(6)	$5,500	GENERAL SUPPORT
PREVENT CANCER FOUNDATION
1600 DUKE STREET SUITE 500	ALEXANDRIA	VA	22314	521429544	501(C)(3)	$14,000	SPONSORSHIP
RESEARCHAMERICA
241 18TH STREET SOUTH SUITE 501	ARLINGTON	VA	22202	521609875	501(C)(3)	$10,000	SPONSORSHIP
SOCIETY FOR WOMEN'S HEALTH RESEARCH
1025 CONNECTICUT AVENUE NW SUITE	WASHINGTON	DC	20036	521694732	501(C)(3)	$10,000	SPONSORSHIP	601
VIRGINIA TECH FOUNDATION INC
902 PRICES FORK ROAD SUITE 4000	BLACKSBURG	VA	24061	540721690	501(C)(3)	$6,500	SPONSORSHIP
WASHINGTON LEGAL FOUNDATION
2009 MASSACHUSETTS AVENUE NW	WASHINGTON	DC	20036	521071570	501(C)(3)	$10,000	CONTRIBUTION

Field	Value	IRS element (for citing)
Total501c3 Org	20	Total501c3OrgCnt
Total Other Org	17	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Travel For Companions	Yes (X)	TravelForCompanionsInd
Discretionary Spending Acct	Yes (X)	DiscretionarySpendingAcctInd
Club Dues Or Fees	Yes (X)	ClubDuesOrFeesInd
Written Policy Ref T And E Expnss	0	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (1)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (1)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JAMES C GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER	$3,395,824	$0	$940,800	$0	$45,600	$0	$812,149	$0	$76,600	$0	$5,270,973	$0	$0	$0
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER	$303,250	$0	$100,800	$0	$0	$0	$36,000	$0	$34,851	$0	$474,901	$0	$0	$0
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC	$470,557	$0	$230,813	$0	$0	$0	$36,000	$0	$35,486	$0	$772,856	$0	$0	$0
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIV	$470,557	$0	$230,813	$0	$0	$0	$36,000	$0	$30,932	$0	$768,302	$0	$0	$0
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT	$390,363	$0	$127,652	$0	$0	$0	$36,000	$0	$19,320	$0	$573,335	$0	$0	$0
DANIEL DURHAM
EVP, HEALTH POLICY	$436,687	$0	$142,800	$0	$0	$0	$36,000	$0	$33,241	$0	$648,728	$0	$0	$0
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY	$323,663	$0	$105,840	$0	$0	$0	$36,000	$0	$14,968	$0	$480,471	$0	$0	$0
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS	$362,088	$0	$118,405	$0	$0	$0	$36,000	$0	$36,041	$0	$552,534	$0	$0	$0
KATHLEEN HOLCOMBE
SVP, SCIENCE POLICY (PARTIAL YEAR)	$340,555	$0	$93,890	$0	$0	$0	$7,226	$0	$1,924	$0	$443,595	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	JAMES GREENWOOD: - NOT INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - FIRST CLASS OR CHARTER TRAVEL - $4,026 - HEALTH OR SOCIAL CLUB DUES OR INITIATION FEES - $5,000 - INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - TRAVEL FOR COMPANIONS - $1,149
PART I, LINE 1B	THE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES.
PART I, LINE 4B	JAMES GREENWOOD - 457(F) $1,940,470

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxt	TransactionTransactionAmt	TransactionTransactionDesc	Sharing Of RevenuesSharingOfRevenuesInd
LAURA GREENWOOD
DAUGHTER OF CEO	$71,553	PAID EMPLOYEE OF ORGANIZATION	0
LILY DOEFLER
DAUGHTER OF A BOARD MEMBER	$33,944	PAID EMPLOYEE OF ORGANIZATION	0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1	THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION (THIS BUDGET LIMITATION WAS REMOVED AT THE END OF 2017 BY A BYLAW CHANGE), OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. AT THE DECEMBER 6, 2017, MEETING OF THE BIO FULL BOARD OF DIRECTORS, THE BOARD CONSIDERED AND APPROVED PROPOSED AMENDMENTS TO THE ORGANIZATION'S BYLAWS, WHICH ALLOW THE EXECUTIVE COMMITTEE (INSTEAD OF THE BOARD) TO APPROVE THE ORGANIZATION'S ANNUAL BUDGET. UPON MOTION, MOVED AND SECONDED, THE RESOLUTION TO AMEND THE BYLAWS, AND THE ACCOMPANYING PROPOSAL TO CHANGE THE GOVERNANCE AND STRATEGIC PLANNING PROCESS, WERE APPROVED WITHOUT OBJECTION, AS PRESENTED.
FORM 990, PART VI, SECTION A, LINE 6	THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7A	AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15	FOR 2017, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2017, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19	THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11G	EC EMERGING PRIORITIES 5,737,318. CONSULTANTS AND OTHER PROFESSIONAL FEES 1,997,572. ECONOMIC STUDIES 325,137. WORKPLAN OBJECTIVES 136,051. TEMPORARY HELP 133,692. EDUCATION 76,086. PROGRAM INITIATIVES 32,972. INTERNS 32,468. BIO-PAC ADMINISTRATIVE 30,783. RECRUITMENT 21,676. BUSINESS STRATEGIES 10,331. CEO DELEGATION EXPENSE 649. I&E INITIATIVES 350.